Form 8-K - Current report:
SEC Accession No. 0001193125-25-122480
Filing Date
2025-05-19
Accepted
2025-05-19 16:29:15
Documents
21
Period of Report
2025-05-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d60311d8k.htm   iXBRL 8-K 37984
2 EX-1.1 d60311dex11.htm EX-1.1 211767
3 EX-1.2 d60311dex12.htm EX-1.2 77534
4 EX-4.1 d60311dex41.htm EX-4.1 438398
5 EX-4.2 d60311dex42.htm EX-4.2 299577
6 EX-5.1 d60311dex51.htm EX-5.1 26151
7 EX-5.2 d60311dex52.htm EX-5.2 61488
12 GRAPHIC g60311dsp1.jpg GRAPHIC 3732
13 GRAPHIC g60311g0517072458377.jpg GRAPHIC 2964
  Complete submission text file 0001193125-25-122480.txt   1545631

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA pfe-20250514.xsd EX-101.SCH 3869
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pfe-20250514_def.xml EX-101.DEF 13234
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pfe-20250514_lab.xml EX-101.LAB 21858
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pfe-20250514_pre.xml EX-101.PRE 14136
24 EXTRACTED XBRL INSTANCE DOCUMENT d60311d8k_htm.xml XML 5514
Mailing Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192
Business Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192 2127332323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

EIN.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03619 | Film No.: 25964405
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)